Cycle Time. Both Parties acknowledge the importance of efficient use of manufacturing capacity to ensure supply of [***]. To that end both Parties agree to strive for a [***] of [***] for the commercial manufacturing with [***] process within [***] post PPQ. It is recognized that the current [***]. Lonza and Vaxcyte together will make all reasonable efforts to reduce the [***] to meet the [***] target, for purpose of calculation of KPIs/associated penalties and/or bonuses subject to adjustment based on actual long term efficiency improvements.
Appears in 1 contract
Sources: Development and Manufacturing Services Agreement (Vaxcyte, Inc.)
Cycle Time. Both Parties acknowledge the importance of efficient use of manufacturing capacity to ensure supply of [***]. To that end both Parties agree to strive for a [***] of [***] for the commercial manufacturing with [***] process within [***] post PPQ. It is recognized that the current [***] is [***]. Lonza and Vaxcyte together will make all reasonable efforts to reduce the [***] to meet the [***] target, for purpose of calculation of KPIs/associated penalties and/or bonuses subject to adjustment based on actual long term efficiency improvements.
Appears in 1 contract
Sources: Development and Manufacturing Services Agreement (Vaxcyte, Inc.)